Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C012729 |
2-amino-4-phosphonobutyric acid |
2-amino-4-phosphonobutyric acid results in increased expression of DLX2 protein | increases expression | 16806298
|
C012729 |
2-amino-4-phosphonobutyric acid |
Glycine Agents inhibits the reaction [2-amino-4-phosphonobutyric acid results in increased expression of DLX2 protein] | decreases reaction|increases expression | 16806298
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of DLX2 mRNA | affects expression | 16483693
|
C004984 |
apocarotenal |
apocarotenal results in increased expression of DLX2 mRNA | increases expression | 17034753
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of DLX2 mRNA | increases expression | 18687144
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of DLX2 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of DLX2 mRNA | increases expression | 20382639
|
D019207 |
beta Carotene |
beta Carotene results in increased expression of DLX2 mRNA | increases expression | 17034753
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA | increases expression | 14729362
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA | affects cotreatment|increases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of DLX2 mRNA | increases expression | 19619570
|
D018684 |
Glycine Agents |
Glycine Agents inhibits the reaction [2-amino-4-phosphonobutyric acid results in increased expression of DLX2 protein] | decreases reaction|increases expression | 16806298
|
D008713 |
Methimazole |
Methimazole results in decreased expression of DLX2 mRNA | decreases expression | 17403546
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of DLX2 mRNA | increases expression | 15674843
|
C494474 |
perchlorate |
perchlorate results in decreased expression of DLX2 mRNA | decreases expression | 17403546
|
D011441 |
Propylthiouracil |
Propylthiouracil results in decreased expression of DLX2 mRNA | decreases expression | 17403546
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of DLX2 mRNA | increases expression | 16966095
|
C017947 |
sodium arsenite |
TP53 protein promotes the reaction [sodium arsenite results in increased expression of DLX2 mRNA] | increases expression|increases reaction | 16966095
|
D014284 |
Triiodothyronine |
Triiodothyronine affects the expression of DLX2 mRNA | affects expression | 17403546
|
D013974 |
Thyroxine |
Thyroxine affects the expression of DLX2 mRNA | affects expression | 17403546
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of DLX2 mRNA | affects cotreatment|increases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA | increases expression | 19619570 16704738 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DLX2 mRNA | increases expression | 17586704
|
D014212 |
Tretinoin |
DKK1 protein promotes the reaction [Tretinoin results in increased expression of DLX2 protein] | increases expression|increases reaction | 17064353
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of DLX2 protein | decreases expression | 17551590
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DLX2 protein | increases expression | 16806298 17064353
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of DLX2 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.03 | 11752688 15322242 14514962 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.03 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.47 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.21 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.21 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.60 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.29 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.62 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.82 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.54 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.87 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.50 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.99 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.02 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
4.89 | 10378619 |
MESH:D001249 |
Asthma |
|
Tretinoin |
4.89 | 16456186 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18728693 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 18985861 17688650 18177632 18940202 20603192 18396377 18558336 19232924 18316065 19460635 15238991 17507914 16609825 17157402 18775368 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.32 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.03 | 20046352 17594078 |
MESH:D001768 |
Blister |
|
Mustard Gas |
5.07 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Propylthiouracil |
14.95 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.95 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.95 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.71 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.83 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.83 | 8888407 |
MESH:D002545 |
Brain Ischemia |
|
beta Carotene |
5.01 | 16157235 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.90 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.90 | 17261762 12948864 19861407 17018787 17289903 14630087 18497071 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.90 | 16166294 16443354 16873071 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
5.07 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.90 | 17687719 10378619 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.50 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.38 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.73 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.08 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.53 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.53 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
4.53 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
7.36 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.36 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.36 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.93 | 18670907 18850075 16120746 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
6.93 | 18093424 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.04 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.84 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.84 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.84 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.50 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.68 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.08 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.08 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.64 | 15340226 8697196 16354765 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.64 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.62 | 17035595 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.98 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 9187081 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.71 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.71 | 16925845 9224671 9664655 9142499 8800419 9211117 17551590 9125849 10589399 14991402 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.71 | 17688650 16575769 8888407 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.65 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.33 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.69 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.69 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.69 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.96 | 1851702 |
MESH:D004487 |
Edema |
|
Mustard Gas |
6.57 | 9260866 11402378 11428647 11428631 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.57 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.67 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.67 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.22 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.22 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.94 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.07 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.84 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.89 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.51 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.21 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.98 | 3659116 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
5.07 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.27 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.27 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.61 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.61 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
3.22 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.37 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.81 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.04 | 18558336 8888407 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.33 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.33 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.59 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
2.95 | 17312396 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.22 | 18801409 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.51 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.12 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.08 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.82 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.82 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.25 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.81 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.95 | 15709030 |
MESH:D015658 |
HIV Infections |
|
beta Carotene |
4.00 | 16960176 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.08 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.67 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.78 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 16959395 18606429 16354765 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.14 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.48 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18850075 18670907 |
MESH:D006980 |
Hyperthyroidism |
|
Methimazole |
5.53 | 14678291 |
MESH:D007037 |
Hypothyroidism |
|
Methimazole |
11.66 | 18031379 |
MESH:D007037 |
Hypothyroidism |
|
Propylthiouracil |
11.66 | 8137927 18031379 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
2.93 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
4.89 | 8975870 11402378 9260866 9357497 11428620 11428631 17524151 11428647 16001271 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.89 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.91 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.68 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.66 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.66 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.94 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.94 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.91 | 15610895 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.73 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.62 | 16932348 16482212 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.83 | 19850784 17596541 16294345 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.83 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.09 | 17301526 17712046 19029980 17361223 17506722 16823087 12679006 16891316 16140955 17649720 19225113 17107899 16935935 19075265 17368321 16788101 16331271 9834237 17217047 17294898 19035177 17339181 16766008 19642359 15748426 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.24 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.38 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.38 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.38 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.19 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.19 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.19 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta Carotene |
6.05 | 17113696 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.05 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
7.34 | 18702808 18161513 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.34 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.18 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.94 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.49 | 18816296 17053015 20064080 20869020 18569708 6695378 20464547 20135361 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
beta Carotene |
6.49 | 16401635 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
6.49 | 3148597 8781369 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.49 | 19931552 15276417 17077188 17306315 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.49 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
2.50 | 11807958 17203775 16891317 11408345 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.40 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.75 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.29 | 16487513 19082730 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.29 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.34 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.15 | 16166281 18303189 16966607 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.13 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.12 | 16381670 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.94 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.23 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.23 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.95 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.21 | 16810080 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.57 | 11141357 |
MESH:D009369 |
Neoplasms |
|
beta Carotene |
11.57 | 17051425 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.57 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.57 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.58 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.65 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.83 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.83 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.83 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.82 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.82 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.82 | 8888407 16359493 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
3.89 | 16761898 7688884 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
7.71 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
7.71 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
7.71 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.83 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.43 | 15976015 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.17 | 12520081 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.81 | 10923243 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.71 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.47 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.18 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.18 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.80 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.55 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.55 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.55 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.52 | 16636307 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
4.01 | 18058305 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.46 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.71 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
5.80 | 17975199 17365031 15814490 17322281 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.80 | 17894541 17720292 17266442 17620002 10334151 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.75 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.58 | 16283617 16116481 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.06 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.68 | 1511512 11738929 16876388 17978042 14763951 3137016 11044598 15475178 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.69 | 15451306 12880345 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
17.48 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
17.48 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
17.48 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
17.48 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
17.48 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.31 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.31 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.46 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
beta Carotene |
5.01 | 17638125 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.32 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.32 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
beta Carotene |
4.18 | 12500499 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
12.10 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
12.10 | 19910387 |
MESH:D013964 |
Thyroid Neoplasms |
|
Propylthiouracil |
7.20 | 15710170 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.20 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.60 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.71 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.15 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.17 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.44 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.94 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
4.94 | 11723127 16452187 16712894 17306315 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.56 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.15 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.15 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.53 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.34 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.51 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.97 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.17 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.89 | 16287080 |